Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?

To: Double Dipper who wrote (187)	1/23/1998 1:57:00 PM
From: Todd D. Wiener	Read Replies (3) \| Respond to of 420

BUYING OP! Kevin- The apparent breakout several days ago was only a head-fake. There was inadequate volume to signify a real breakout. But today's drop was accompanied by little selling pressure, indicating that this is a blowoff bottom, I think. The support at $11.75 will hold, as the stock sees the remaining weak hands sell out. NOV releases earnings next week, as does NCES, and it should be positive. The stock apparently needed to fall to below $12, in order to gather enough buying support to drive it into the high teens. My year-end target for NOV is $20, and my price target for NCES is $12. As I type, I am placing an order to triple my position in NCES and increase my NOV position by 50%. Todd